
Teva pharmaceutical industries director Roberto Mignone sells $6.29m in shares
Published on December 26, 2024
shares held by Swiftcurrent Master Fund, Ltd., except for his indirect pecuniary interest. For investors monitoring insider transactions,

shares held by Swiftcurrent Master Fund, Ltd., except for his indirect pecuniary interest. For investors monitoring insider transactions,